Clinical Trial Results:
A Double-Blind, Placebo-Controlled, Randomized, Multi-Center, Dose-Finding Study of SLV320, a Selective A1 Adenosine Receptor Antagonist, to Evaluate the Effect on Renal Function and Safety in Subjects Hospitalized with Acute Decompensated Heart Failure and Renal Dysfunction (Reno-Defend 1)
Summary
|
|
EudraCT number |
2008-003786-20 |
Trial protocol |
DE DK PL IT FR |
Global completion date |
04 Jan 2010
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
12 Jun 2016
|
First version publication date |
12 Jun 2016
|
Other versions |
|
Summary report(s) |
S320.2.011 Study |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.